Drug discovery company Atomwise lands $123M in Series B funding

https://www.mobihealthnews.com/news/drug-discovery-company-atomwise-lands-123m-series-b-funding

This morning artificial intelligence-based drug discovery platform Atomwise scored a whopping $123 million in Series B funding led by B Capital Group and Sanabil Investments. DCVC, BV, Tencent, Y Combinator, Dolby Family Venture and AME Cloud Ventures also participated in the funding round. 

WHAT IT DOES

The company uses artificial intelligence,

 » ….